Identification of families with cortical Lewy body disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 128 B, Issue 1, 2004, Pages 118-122

  Harding, Antony J ^a,d   Das, Anurina ^a   Kril, Jillian J ^b   Brooks, William S ^a,b   Duffy, David ^c   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Dementia with Lewy bodies; Dominant inheritance; Parkinson's disease; Recessive inheritance

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; INHERITANCE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL;

EID: 3042802238     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30014     Document Type: Article

References (32)

1. Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. 2002. Parkinson disease neuropathology. Later developing dementia and loss of the levodopa response. Arch Neurol 59:102-112.
2. Armstrong RA, Cairns NJ, Lantos PL. 1998. The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies. Exp Neurol 150:122-127.
3. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
4. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF; Longley W, Anthony JC. 1990. A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707.
5. Davie AM. 1979. The 'singles' method for segregation analysis under incomplete ascertainment. Ann Hum Genet 42:507-510.
6. Denson MA, Wszolek ZK, Pfeiffer RF, Wszolek EK, Paschall TM, McComb RD. 1997. Familial parkinsonism, dementia, and Lewy body disease: Study of family G. Ann Neurol 42:638-643.
7. Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S, Dartigues JF, Alpérovitch A, Tzourio C, Rocca WA. 1999. Familial aggregation of Parkinson's disease: A population-based case-control study in Europe. Neurology 52:1876-1882.
8. Finckh U. 2003. The future of genetic association studies in Alzheimer's disease. J Neural Transm 110:253-266.
9. Galvin JE, Lee SL, Perry A, Havlioglu N, McKeel DW Jr, Morris JC. 2002. Familial dementia with Lewy bodies. Clinicopathological analysis of two kindreds. Neurology 59:1079-1082.
10. Gelb DJ, Oliver E, Gilman S. 1999. Diagnostic criteria for Parkinson's disease. Arch Neurol 56:33-39.
11. Harding AJ, Halliday GM. 2001. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355-363.
12. Harding AJ, Broe GA, Halliday GM. 2002a. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125:391-403.
13. Harding AJ, Stimson E, Henderson JM, Halliday GM. 2002b. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 125:2431-2445.
14. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. 1999. The Sydney multicentre study of Parkinson's disease: Progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67:300-307.
15. Houlden H, Crook R, Dolan RJ, McLaughmin J, Revesz T, Hardy J. 2001. A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies. Neurosci Lett 313:93-95.
16. Ishikawa A, Takahashi H, Tanaka H, Hayashi T, Tsuji S. 1997. Clinical features of familial diffuse Lewy body disease. Eur Neurol 38(Suppl 1): 34-38.
17. Lippa CF, Schmidt ML, Lee VM-Y, Trojanowski JQ. 2001. α-Synuclein in familial Alzheimer's disease. Arch Neurol 58:1817-1820.
18. Marder K, Tang M-X, Alfaro B, Mejia H, Cote L, Louis E, Stern Y, Mayeux R. 1999. Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 52:719-724.
19. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47:1113-1124.
20. McKeith IG, Perry EK, Perry RH. 1999. Report of the second dementia with Lewy body international workshop. Neurology 53:902-905.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price DL, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34:939-944.
22. Mickel SF, Broste SK, Hiner BC. 1997. Lack of overlap in genetic risks for Alzheimer's disease and Parkinson's disease. Neurology 48:942-949.
23. Mirra SS, Heyman A, McKeel D, Crain BJ, Brownlee LM, Vogel FS. 1991. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
24. Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM Jr, Snow BJ, Calne DB. 1998. Hereditary form of Parkinsonism-dementia. Ann Neurol 43:768-781.
25. National Breast Cancer Genetics Working Group. 1998. Current best advice about familial aspects of breast cancer. A guide for general practitioners. http://www.nbcc.org.au/pages/info/resource/nbccpubs/advice.htm.
26. Ohara K, Takauchi S, Kokai M, Morimura Y, Nakajima T, Morita Y. 1999. Familial dementia with Lewy bodies (DLB). Clin Neuropathol 18:232-239.
27. Revesz T, McLaughlin JL, Rossor MN, Lantos PL. 1997. Pathology of familial Alzheimer's disease with Lewy bodies. J Neural Transm Suppl 51:121-135.
28. Saunders AM. 2001. Gene identification in Alzheimer's disease. Pharmacogenetics 2:239-249.
29. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. 2001. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation. Ann Neurol 49:313-319.
30. The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18:S1-S2.
31. Tsuang DW, Dalan AM, Eugenio CJ, Limprasert P, Le Spada AR, Steinbart EJ, Bird TD, Leverenz JB. 2002. Familial dementia with Lewy bodies: A clinical and neuropathological study of two families. Arch Neurol 59:1622-1630.
32. Wakabayashi K, Hayashi S, Ishikawa A, Hayashi T, Okuizumi K, Tanaka H, Tsuji S, Takahashi H. 1998. Autosomal dominant diffuse Lewy body disease. Acta Neuropathol 96:207-210.